Regulatory T cells and inflammatory bowel disease (Q33740189)

29 July 2017

1 reference

title

Regulatory T cells and inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

29 July 2017

0 references

author name string

Groux H

series ordinal

1

1 reference

PubMed ID

10500290

29 July 2017

Powrie F

series ordinal

2

1 reference

PubMed ID

10500290

29 July 2017

language of work or name

1 reference

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

20

1 reference

29 July 2017

10

1 reference

29 July 2017

442-445

1 reference

T cells in inflammatory bowel disease: protective and pathogenic roles.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Experimental models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Gi2 alpha protein deficiency: a model of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Antibodies to interleukin 12 abrogate established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Altered immune responses in interleukin 10 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

1 reference

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

Transforming growth factor beta: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901510-8

7 January 2021

10.1016/S0167-5699(99)01510-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10500290